Non-metabolic membrane tubulation and permeability induced by bioactive peptides

PLoS ONE

Volumn 2, Issue 2, 2007, Pages

  Lamazière, Antonin ^a   Burlina, Fabienne ^b   Wolf, Claude ^a   Chassaing, Gérard ^b   Trugnan, Germain ^a   Ayala Sanmartin, Jesus ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; PENETRATIN; PEPTIDE; PEPTIDE RL16; PEPTIDE RW16; PEPTIDE RW9; POLYARGININE; POLYPEPTIDE; SUBSTANCE P; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; DRUG CARRIER; GREEN FLUORESCENT PROTEIN; LIPOCORTIN 2; MEMBRANE LIPID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL VACUOLE; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; INTERNALIZATION; MEMBRANE PERMEABILITY; MICROSCOPY; MICROTUBULE; MOLECULAR SIZE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TOXICITY TESTING; TURBIDIMETRY; X RAY DIFFRACTION; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CHO CELL; CLASSIFICATION; COMPARATIVE STUDY; CRICETULUS; DRUG EFFECT; DRUG SCREENING; HAMSTER; LIPID BILAYER; MEMBRANE FUSION; METABOLISM; MOLECULAR GENETICS; PERMEABILITY; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANNEXIN A2; CARRIER PROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GREEN FLUORESCENT PROTEINS; HYDROPHOBICITY; LIPID BILAYERS; MEMBRANE FUSION; MEMBRANE LIPIDS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PERMEABILITY; PROTEIN STRUCTURE, SECONDARY; SUBSTANCE P;

EID: 34548143984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000201     Document Type: Article

References (54)

1. Dietz GP, Bahr M (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 27: 85-131.
2. Nekhotiaeva N, Elmquist A, Rajarao GK, Hallbrink M, Langel U, et al. (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. Faseb J 18: 394-396.
3. Palm C, Netzereab S, Hallbrink M (2006) Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27: 1710-1716.
4. Duplaa H, Convert O, Sautereau AM, Tocanne JF, Chassaing G (1992) Binding of substance P to monolayers and vesicles made of phosphatidylcholine and/or phosphatidylserine. Biochim Biophys Acta 1107: 12-22.
5. Oehlke J, Lorenz D, Wiesner B, Bienert M (2005) Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides. J Mol Recognit 18: 50-59.
6. Perez F, Liedo PM, Karagogeos D, Vincent JD, Prochiantz A, et al. (1994) Rab3A and Rab3B carboxy-terminal peptides are both potent and specific inhibitors of prolactin release by rat cultured anterior pituitary cells. Mol Endocrinol 8: 1278-1287.
7. Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19: 1173-1176.
8. Hallbrink M, Floren A, Elmquist A, Pooga M, Bartfai T, et al. (2001) Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta 1515: 101-109.
9. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
10. Huang HW (2006) Molecular mechanism of antimicrobial peptides: The origin of cooperativity. Biochim Biophys Acta.
11. Matsuzaki K, Yoneyama S, Miyajima K (1997) Pore formation and translocation of melittin. Biophys J 73: 831-838.
12. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
13. Yang L, Weiss TM, Lehrer RI, Huang HW (2000) Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J 79: 2002-2009.
14. Drin G, Cottin S, Blanc E, Rees AR, Temsamani J (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 278: 31192-31201.
15. Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giarca M, et al. (2003) Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther 8: 284-294.
16. Khalil IA, Kogure K, Futaki S, Harashima H (2006) High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 281: 3544-3551.
17. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, et al. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271: 18188-18193.
18. Vives E (2005) Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?" J Control Release 109: 77-85.
19. Berlose JP, Convert O, Derossi D, Brunissen A, Chassaing G (1996) Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem 242: 372-386.
20. Bellet-Amalric E, Blaudez D, Desbat B, Graner F, Gauthier F, et al. (2000) Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer, studied by ellipsometry and PM-IRRAS at the air-water interface. Biochim Biophys Acta 1467: 131-143.
21. Magzoub M, Eriksson LE, Graslund A (2003) Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles. Biophys Chem 103: 271-288.
22. Balayssac S, Burlina F, Convert O, Bolbach G, Chassaing G, et al. (2006) Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. Biochemistry 45: 1408-1420.
23. Thoren PE, Persson D, Esbjorner EK, Goksor M, Lincoln P, et al. (2004) Membrane binding and translocation of cell-penetrating peptides. Biochemistry 43: 3471-3489.
24. Terrone D, Sang SL, Roudaia L, Silvius JR (2003) Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry 42: 13787-13799.
25. Drin G, Demene H, Temsamani J, Brasseur R (2001) Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry 40: 1824-1834.
26. Hitz T, Iten R, Gardiner J, Namoto K, Walde P, et al. (2006) Interaction of alpha-and beta-oligoarginine-acids and amides with anionic lipid vesicles: a mechanistic and thermodynamic study. Biochemistry 45: 5817-5829.
27. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269: 10444-10450.
28. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 56: 318-325.
29. Derossi D, Chassaing G, Prochiantz A (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 8: 84-87.
30. Lee MT, Hung WC, Chen FY, Huang HW (2005) Many-body effect of antimicrobial peptides: on the correlation between lipid's spontaneous curvature and pore formation. Biophys J 89: 4006-4016.
31. Chen FY, Lee MT, Huang HW (2003) Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 84: 3751-3758.
32. Huang HW, Chen FY, Lee MT (2004) Molecular mechanism of Peptide-induced pores in membranes. Phys Rev Lett 92: 198304.
33. Li C, Salditt T (2006) Structure of magainin and alamethicin in model membranes studied by x-ray reflectivity. Biophys J.
34. Siegel DP, Cherezov V, Greathouse DV, Koeppe RE 2nd, Killian JA, et al. (2006) Transmembrane peptides stabilize inverted cubic phases in a biphasic length-dependent manner: implications for protein-induced membrane fusion. Biophys J 90: 200-211.
35. Chachaty C, Rainteau D, Tessier C, Quinn PJ, Wolf C (2005) Building up of the liquid-ordered phase formed by sphingomyelin and cholesterol. Biophys J 88: 4032-4044.
36. Magzoub M, Kilk K, Eriksson LE, Langel U, Graslund A (2001) Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim Biophys Acta 1512: 77-89.
37. Mangavel C, Maget-Dana R, Tauc P, Brochon JC, Sy D, et al. (1998) Structural Investigations of basic amphipathic model peptides in the presence of lipid vesicles studied by circular dichroism, fluorescence,.monolayer and modeling. Biochim Biophys Acta 1371: 265-283.
38. Ambroggio EE, Separovic F, Bowie JH, Fidelio GD, Bagatolli LA (2005) Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein. Biophys J 89: 1874-1881.
39. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
40. Magzoub M, Eriksson LE, Graslund A (2002) Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration. Biochism Biophys Acta 1563: 53-63.
41. Persson D, Thoren PE, Norden B (2001) Penetratin-induced aggregation and subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett 505: 307-312.
42. Binder H, Lindblom G (2004) A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. Biophys J 87: 332-343.
43. Persson D, Thoren PE, Lincoln P, Norden B (2004) Vesicle membrane interactions of penetratin analogues. Biochemistry 43: 11045-11055.
44. Menger FM, Seredyuk VA, Kitaeva MV, Yaroslavov AA, Melik-Nubarov NS (2003) Migration of poly-L-lysine through a lipid bilayer. J Am Chem Soc 125: 2846-2847.
45. Farge E, Devaux PF (1992) Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. Biophys J 61: 347-357.
46. Ranch C, Farge E (2000) Endocytosis switch controlled by transmembrane osmotic pressure and phospholipid number asymmetry. Biophys J 78: 3036-3047.
47. Goncalves E, Kitas E, Seelig J (2005) Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 44: 2692-2702.
48. Brattwall CE, Lincoln P, Norden B (2003) Orientation and conformation of cell-penetrating peptide penetratin in phospholipid vesicle membranes determined by polarized-light spectroscopy. J Am Chem Soc 125: 14214-14215.
49. Puff N, Lamaziere A, Seigneuret M, Trugnan G, Angelova MI (2005) HDLs induce raft domain vanishing in heterogeneous giant vesicles. Chem Phys Lipids 133: 195-202.
50. Lambert O, Cavusoglu N, Gallay J, Vincent M, Rigaud JL, et al. (2004) Novel organisation and properties of annexin 2-membrane complexes. J Biol Chem 279: 10872-10882.
51. Ladokhin AS, Jayasinghe S, White SH (2000) How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal Biochem 285: 235-245.
52. Tessier C, Quinn P, Koumanov K, Trugnan G, Rainteau D, et al. (2004) Modulation of the phase heterogeneity of aminoglycerophospholipid mixtures by sphingomyelin and monovalent cations: maintenance of the lamellar arrangement in the biological membranes. Eur Biophys J 33: 513-521.
53. McIntosh TJ, Kulkarni KG, Simon SA (1999) Membrane fusion promoters and inhibitors have contrasting effects on lipid bilayer structure and undulations. Biophys J 76: 2090-2098.
54. Ayala-Sanmartin J, Cavusoglu N, Masliah J, Trugnan G (2004) Homodimerization of Annexin 2. Role of the N-terminal tail and modulation of membrane aggregation properties. Annexins 1: 19-25.